In contrast, we have recently demonstrated anti-tumorigenic effects of 10058-F4 in two tumor models of MYCN-amplified neuroblastoma, suggesting that direct MYC inhibition using a small molecule is achievable in vivo[36]. The gene discussed is MYC; the disease is neuroblastoma.